An agreement was signed between the Algerian firm Pharma Invest SPA and the Chinese Yangtze River Pharmaceutical Group, overseen by the Minister of Pharmaceutical Industry. The partnership focuses on transferring modern technology and expertise to master the production of pharmaceutical raw materials and to foster the manufacturing of innovative drugs locally. This initiative aims to improve local production standards and support national health sovereignty. Furthermore, discussions were held regarding a future cooperation between Pharma Invest and the public group Saidal for the production and distribution of high-value-added medicines. The Minister highlighted that these efforts are crucial for mastering advanced technologies and strengthening the national industrial landscape.